跳至主要内容
临床试验/NCT02984215
NCT02984215已完成不适用

Array-CGH in Plasma Cell Post-transplantation Lymphoproliferative Disorders

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 1990年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Genome wide array-based comparative genomic hybridization (aCGH)

研究概览

简要总结

Plasma-cell post-transplantation lymphoproliferative disorders (PC-PTLD) are rare monomorphic PTLD divided into plasma cell myeloma (PCM) and plasmacytoma-like lesion (PLL) PTLD. To date, there is no exhaustive published cytogenetic data on PC-PTLD. The investigators report array-based comparative genomic hybridization (aCGH) of 10 cases of PCM and PLL-PTLD.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • WHO classification 2008 as monomorphic PCM (plasma cell myeloma) or PLL (plasmacytoma like lesion) / PTLD (post transplantation lymphoproliferative disorders).

排除标准

  • Other than PCM or PLL PTLD at diagnosis

结局指标

主要结局

Genome wide array-based comparative genomic hybridization (aCGH)

时间窗: At diagnosis of PTLD, Day 0.

次要结局

  • Overall survival according to aCGH complexity(Overall survival (OS) was calculated from date of diagnosis to date of death from any cause, up to 130 months.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

aCGH Impacts Survival in Plasma Cell PTLD | 临床试验